An economic evaluation of donepezil in the treatment of Alzheimer's disease
- 1 July 1998
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (4) , 838-850
- https://doi.org/10.1016/s0149-2918(98)80145-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics SocietyPublished by American Medical Association (AMA) ,1997
- Cognitive Function and the Costs of Alzheimer DiseaseArchives of Neurology, 1997
- The economic impact of tacrine in the treatment of Alzheimer's diseaseClinical Therapeutics, 1997
- Long-term tacrine (Cognex) treatmentNeurology, 1996
- Proxy response patterns among the aged: Effects on estimates of health status and medical care utilization from the 1982–1984 long-term care surveysJournal of Clinical Epidemiology, 1996
- The Cost of Alzheimerʼs DiseasePharmacoEconomics, 1996
- The US economic and social costs of Alzheimer's disease revisited.American Journal of Public Health, 1994
- The Economic Burden of Alzheimer's Disease CareHealth Affairs, 1993
- Tacrine for treating Alzheimer's diseaseJAMA, 1992
- Estimated Prevalence of Alzheimer's Disease in the United StatesThe Milbank Quarterly, 1990